Eko Analysis Software vs Cardiomo

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Eko Devices
VS
by Cardiomo, Inc.

AI Verdict

These tools are adjacent competitors, both focusing on AI-powered cardiovascular disease detection and remote monitoring. Eko Analysis Software is best suited for clinicians seeking an AI-powered auscultation assistant integrated with digital stethoscopes, while Cardiomo targets continuous, long-term remote monitoring via a wearable patch for patients and caregivers.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if you are a clinician seeking an FDA-cleared, AI-powered tool to enhance point-of-care cardiovascular disease detection during physical exams. It's ideal for quickly identifying heart murmurs and atrial fibrillation, recording and visualizing heart sounds and ECGs, and integrating these capabilities into existing clinical workflows, including telehealth.

View Eko Analysis Software →

Choose Cardiomo if…

Choose Cardiomo if you require continuous, remote heart health monitoring for patients, particularly for long-term oversight of cardiovascular conditions and timely alerts to caregivers. This medical-grade wearable is well-suited for detecting arrhythmias and other cardiovascular events 24/7, offering peace of mind for both patients and their support network.

View Cardiomo →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Analysis Software Cardiomo
Pricing Freemium with subscription for full features Contact for pricing
Deployment Cloud-based Cloud-based with wearable device and mobile app
FDA Status 1 AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Analysis Software

Eko Analysis Software integrates with familiar digital stethoscopes, offering a seamless workflow for clinicians during routine exams. Its mobile app and web dashboard provide clear visualizations and guided exam flows, making it intuitive for healthcare professionals. Cardiomo, while aiming for user-friendliness with its wearable patch, introduces a new device and continuous monitoring paradigm that might require a greater adjustment for both patients and caregivers.

Clinical Value

Eko Analysis Software

Eko Analysis Software has multiple FDA clearances for detecting heart murmurs and atrial fibrillation, with published clinical validation studies demonstrating high sensitivity and specificity. Cardiomo also uses AI for disease detection and provides real-time alerts, but specific details on its clinical validation studies and FDA clearance status are less prominent in the provided information, although it mentions ISO 13485 certification and CE Mark Class IIa Medical Device status.

Pricing & Value

Eko Analysis Software

Eko Analysis Software offers a freemium model with transparent subscription pricing for full AI features, allowing users to understand costs upfront. Cardiomo's current pricing is not publicly available, making it difficult to assess its value proposition without direct contact for a quote.

Enterprise Readiness

Eko Analysis Software

Eko Analysis Software is positioned as an enterprise solution with its SENSORA platform, designed for health systems to scale AI-powered cardiac detection across specialties. It also offers features like EHR integration and a web dashboard for program management. Cardiomo focuses on remote monitoring and alerts for individuals and caregivers, with less emphasis on broad enterprise-level deployment features in the provided information.

Innovation

Tie

Both tools demonstrate significant innovation in cardiovascular AI. Eko innovates by enhancing traditional auscultation with AI-powered digital stethoscopes for early detection at the point of care. Cardiomo innovates with its medical-grade wearable patch for continuous, remote monitoring and real-time alerts, representing a shift towards proactive, continuous health tracking.

Support & Docs

Eko Analysis Software

Eko provides extensive support and documentation, including a comprehensive help center with FAQs, user manuals in multiple languages, and direct contact options for support. While Cardiomo offers a mobile application and aims to reduce the distance between patient and practitioner, specific details about its support resources and documentation are not as readily available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Analysis Software Cardiomo
Product Name Eko Analysis Software Cardiomo
Company Eko Devices Cardiomo, Inc.
Key AI Detection Capabilities FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, Detection of normal sinus rhythm AI-powered disease detection (arrhythmias, cardiovascular events)
Categories Cardiology AI, Wearables & Remote Monitoring (RPM) Cardiology AI, Wearables & Remote Monitoring (RPM)

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and Cardiomo.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app, allowing for recording, playback, and annotation of heart sounds and ECGs. It offers EHR integration, enabling clinicians to view the dashboard within their EHR system and push AI analysis results via PDF or anonymous URL. Cardiomo, with its wearable device and mobile app, transmits data via Bluetooth to a mobile device and then to cloud storage in real-time. Cardiomo also offers RESTful API, webhooks, and pre-built integrations for seamless connection with existing platforms.
Eko's AI for heart murmur detection has a sensitivity of 90.0% and specificity of 91.4% (excluding grade 1 murmurs), and for moderate-to-severe aortic stenosis, it has a sensitivity of 93.2% and specificity of 86.0%. Its AFib detection AI has 99% sensitivity and 97% specificity. Cardiomo's sensors achieve 99.2% clinical accuracy, validated through clinical studies, and have 97.8% accuracy during activity.
Eko's platform is designed to elevate detection and monitoring with advanced sensors, software, and AI-powered analysis, suggesting a focus on enhancing existing clinical expertise. Cardiomo is described as user-friendly and practical, aiming to provide continuous heart monitoring with ease of use.
Eko provides numerous customer stories and case studies, including examples of streamlining internal processes for large organizations like AirAsia and Marriott County Hall, and delivering high-acuity care at home with its telehealth platform. Cardiomo has been successfully tested in pilot projects with major state healthcare institutions and private clinics in Ukraine, Austria, and Portugal, and also with employees working in dangerous conditions.
While specific audit-trail features for Eko are not detailed, EHR integrations generally include event logging and user authentication to track access to patient data. For Cardiomo, the information provided does not explicitly detail audit-trail features, but strong security postures often include such capabilities.
Eko Analysis Software is designed for early detection of cardiovascular diseases like heart murmurs and atrial fibrillation, and has received FDA clearance for detecting and characterizing murmurs in both adult and pediatric patients. It also has capabilities for detecting low ejection fraction, an indicator of heart failure. Cardiomo focuses on continuous and remote heart health monitoring for detecting cardiovascular diseases and providing timely alerts, with a target audience of individuals aged 45 and above, particularly those with existing heart issues.

Backers

Who funded each tool's parent company.

Eko Analysis Software

Cardiomo

AI Tool Finder
AI-powered search. Results may not be comprehensive.